nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—CYP2D6—Vinorelbine—ovarian cancer	0.0678	0.213	CbGbCtD
Hydromorphone—CYP3A4—Topotecan—ovarian cancer	0.0612	0.192	CbGbCtD
Hydromorphone—CYP2C9—Paclitaxel—ovarian cancer	0.0521	0.164	CbGbCtD
Hydromorphone—CYP3A4—Vinorelbine—ovarian cancer	0.0431	0.135	CbGbCtD
Hydromorphone—CYP3A4—Paclitaxel—ovarian cancer	0.0303	0.0951	CbGbCtD
Hydromorphone—CYP2D6—Doxorubicin—ovarian cancer	0.0257	0.0806	CbGbCtD
Hydromorphone—CYP3A4—Docetaxel—ovarian cancer	0.0219	0.0688	CbGbCtD
Hydromorphone—CYP3A4—Doxorubicin—ovarian cancer	0.0163	0.0513	CbGbCtD
Hydromorphone—Naloxone—TLR4—ovarian cancer	0.00768	0.572	CrCbGaD
Hydromorphone—Naloxone—ESR1—ovarian cancer	0.00215	0.16	CrCbGaD
Hydromorphone—Naltrexone—ABCB1—ovarian cancer	0.00125	0.0935	CrCbGaD
Hydromorphone—Naloxone—ABCB1—ovarian cancer	0.000915	0.0682	CrCbGaD
Hydromorphone—Morphine—ABCB1—ovarian cancer	0.000772	0.0576	CrCbGaD
Hydromorphone—Dextromethorphan—ABCB1—ovarian cancer	0.000649	0.0483	CrCbGaD
Hydromorphone—Pollakiuria—Epirubicin—ovarian cancer	0.000462	0.000691	CcSEcCtD
Hydromorphone—Palpitations—Docetaxel—ovarian cancer	0.000456	0.000683	CcSEcCtD
Hydromorphone—Loss of consciousness—Docetaxel—ovarian cancer	0.000454	0.000679	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000453	0.000678	CcSEcCtD
Hydromorphone—Weight decreased—Epirubicin—ovarian cancer	0.000452	0.000677	CcSEcCtD
Hydromorphone—Cough—Docetaxel—ovarian cancer	0.000451	0.000675	CcSEcCtD
Hydromorphone—Insomnia—Paclitaxel—ovarian cancer	0.00045	0.000673	CcSEcCtD
Hydromorphone—Convulsion—Docetaxel—ovarian cancer	0.000447	0.00067	CcSEcCtD
Hydromorphone—Paraesthesia—Paclitaxel—ovarian cancer	0.000447	0.000668	CcSEcCtD
Hydromorphone—Hypertension—Docetaxel—ovarian cancer	0.000446	0.000667	CcSEcCtD
Hydromorphone—Drowsiness—Epirubicin—ovarian cancer	0.000446	0.000667	CcSEcCtD
Hydromorphone—Infestation—Epirubicin—ovarian cancer	0.000446	0.000667	CcSEcCtD
Hydromorphone—Infestation NOS—Epirubicin—ovarian cancer	0.000446	0.000667	CcSEcCtD
Hydromorphone—Dyspnoea—Paclitaxel—ovarian cancer	0.000443	0.000664	CcSEcCtD
Hydromorphone—Somnolence—Paclitaxel—ovarian cancer	0.000442	0.000662	CcSEcCtD
Hydromorphone—Arthralgia—Docetaxel—ovarian cancer	0.00044	0.000658	CcSEcCtD
Hydromorphone—Chest pain—Docetaxel—ovarian cancer	0.00044	0.000658	CcSEcCtD
Hydromorphone—Myalgia—Docetaxel—ovarian cancer	0.00044	0.000658	CcSEcCtD
Hydromorphone—Nausea—Vinorelbine—ovarian cancer	0.000439	0.000657	CcSEcCtD
Hydromorphone—Dyspepsia—Paclitaxel—ovarian cancer	0.000438	0.000655	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000437	0.000654	CcSEcCtD
Hydromorphone—Stomatitis—Epirubicin—ovarian cancer	0.000435	0.00065	CcSEcCtD
Hydromorphone—Dysuria—Doxorubicin—ovarian cancer	0.000433	0.000647	CcSEcCtD
Hydromorphone—Decreased appetite—Paclitaxel—ovarian cancer	0.000432	0.000647	CcSEcCtD
Hydromorphone—Dry mouth—Docetaxel—ovarian cancer	0.00043	0.000644	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000429	0.000643	CcSEcCtD
Hydromorphone—Fatigue—Paclitaxel—ovarian cancer	0.000429	0.000642	CcSEcCtD
Hydromorphone—Sweating—Epirubicin—ovarian cancer	0.000427	0.00064	CcSEcCtD
Hydromorphone—Pollakiuria—Doxorubicin—ovarian cancer	0.000427	0.00064	CcSEcCtD
Hydromorphone—Constipation—Paclitaxel—ovarian cancer	0.000425	0.000636	CcSEcCtD
Hydromorphone—Pain—Paclitaxel—ovarian cancer	0.000425	0.000636	CcSEcCtD
Hydromorphone—Confusional state—Docetaxel—ovarian cancer	0.000425	0.000636	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000422	0.000631	CcSEcCtD
Hydromorphone—Anaphylactic shock—Docetaxel—ovarian cancer	0.000422	0.000631	CcSEcCtD
Hydromorphone—Infection—Docetaxel—ovarian cancer	0.000419	0.000627	CcSEcCtD
Hydromorphone—Weight decreased—Doxorubicin—ovarian cancer	0.000419	0.000626	CcSEcCtD
Hydromorphone—Shock—Docetaxel—ovarian cancer	0.000415	0.000621	CcSEcCtD
Hydromorphone—Nervous system disorder—Docetaxel—ovarian cancer	0.000413	0.000619	CcSEcCtD
Hydromorphone—Infestation—Doxorubicin—ovarian cancer	0.000412	0.000617	CcSEcCtD
Hydromorphone—Infestation NOS—Doxorubicin—ovarian cancer	0.000412	0.000617	CcSEcCtD
Hydromorphone—Drowsiness—Doxorubicin—ovarian cancer	0.000412	0.000617	CcSEcCtD
Hydromorphone—Tachycardia—Docetaxel—ovarian cancer	0.000411	0.000616	CcSEcCtD
Hydromorphone—Feeling abnormal—Paclitaxel—ovarian cancer	0.00041	0.000613	CcSEcCtD
Hydromorphone—Skin disorder—Docetaxel—ovarian cancer	0.000409	0.000613	CcSEcCtD
Hydromorphone—Bradycardia—Epirubicin—ovarian cancer	0.000407	0.00061	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000407	0.000609	CcSEcCtD
Hydromorphone—Stomatitis—Doxorubicin—ovarian cancer	0.000402	0.000602	CcSEcCtD
Hydromorphone—Anorexia—Docetaxel—ovarian cancer	0.000402	0.000601	CcSEcCtD
Hydromorphone—Rhinitis—Epirubicin—ovarian cancer	0.000401	0.0006	CcSEcCtD
Hydromorphone—Hypoaesthesia—Epirubicin—ovarian cancer	0.000398	0.000596	CcSEcCtD
Hydromorphone—Sweating—Doxorubicin—ovarian cancer	0.000395	0.000592	CcSEcCtD
Hydromorphone—Urinary tract disorder—Epirubicin—ovarian cancer	0.000395	0.000591	CcSEcCtD
Hydromorphone—Urticaria—Paclitaxel—ovarian cancer	0.000395	0.000591	CcSEcCtD
Hydromorphone—Oedema peripheral—Epirubicin—ovarian cancer	0.000394	0.00059	CcSEcCtD
Hydromorphone—Hypotension—Docetaxel—ovarian cancer	0.000394	0.000589	CcSEcCtD
Hydromorphone—Connective tissue disorder—Epirubicin—ovarian cancer	0.000393	0.000589	CcSEcCtD
Hydromorphone—Abdominal pain—Paclitaxel—ovarian cancer	0.000393	0.000588	CcSEcCtD
Hydromorphone—Body temperature increased—Paclitaxel—ovarian cancer	0.000393	0.000588	CcSEcCtD
Hydromorphone—Urethral disorder—Epirubicin—ovarian cancer	0.000392	0.000587	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00039	0.000584	CcSEcCtD
Hydromorphone—Visual impairment—Epirubicin—ovarian cancer	0.000386	0.000577	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000384	0.000575	CcSEcCtD
Hydromorphone—Insomnia—Docetaxel—ovarian cancer	0.000381	0.000571	CcSEcCtD
Hydromorphone—Paraesthesia—Docetaxel—ovarian cancer	0.000378	0.000566	CcSEcCtD
Hydromorphone—Bradycardia—Doxorubicin—ovarian cancer	0.000377	0.000564	CcSEcCtD
Hydromorphone—Dyspnoea—Docetaxel—ovarian cancer	0.000376	0.000562	CcSEcCtD
Hydromorphone—Somnolence—Docetaxel—ovarian cancer	0.000375	0.000561	CcSEcCtD
Hydromorphone—Eye disorder—Epirubicin—ovarian cancer	0.000374	0.00056	CcSEcCtD
Hydromorphone—Tinnitus—Epirubicin—ovarian cancer	0.000373	0.000558	CcSEcCtD
Hydromorphone—Flushing—Epirubicin—ovarian cancer	0.000371	0.000556	CcSEcCtD
Hydromorphone—Cardiac disorder—Epirubicin—ovarian cancer	0.000371	0.000556	CcSEcCtD
Hydromorphone—Rhinitis—Doxorubicin—ovarian cancer	0.000371	0.000556	CcSEcCtD
Hydromorphone—Dyspepsia—Docetaxel—ovarian cancer	0.000371	0.000555	CcSEcCtD
Hydromorphone—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000368	0.000551	CcSEcCtD
Hydromorphone—Decreased appetite—Docetaxel—ovarian cancer	0.000366	0.000548	CcSEcCtD
Hydromorphone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000366	0.000548	CcSEcCtD
Hydromorphone—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000366	0.000547	CcSEcCtD
Hydromorphone—Oedema peripheral—Doxorubicin—ovarian cancer	0.000365	0.000546	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000364	0.000545	CcSEcCtD
Hydromorphone—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000364	0.000545	CcSEcCtD
Hydromorphone—Fatigue—Docetaxel—ovarian cancer	0.000363	0.000544	CcSEcCtD
Hydromorphone—Angiopathy—Epirubicin—ovarian cancer	0.000363	0.000543	CcSEcCtD
Hydromorphone—Urethral disorder—Doxorubicin—ovarian cancer	0.000363	0.000543	CcSEcCtD
Hydromorphone—Immune system disorder—Epirubicin—ovarian cancer	0.000361	0.000541	CcSEcCtD
Hydromorphone—Mediastinal disorder—Epirubicin—ovarian cancer	0.000361	0.00054	CcSEcCtD
Hydromorphone—Constipation—Docetaxel—ovarian cancer	0.00036	0.000539	CcSEcCtD
Hydromorphone—Pain—Docetaxel—ovarian cancer	0.00036	0.000539	CcSEcCtD
Hydromorphone—Chills—Epirubicin—ovarian cancer	0.000359	0.000537	CcSEcCtD
Hydromorphone—Arrhythmia—Epirubicin—ovarian cancer	0.000357	0.000535	CcSEcCtD
Hydromorphone—Visual impairment—Doxorubicin—ovarian cancer	0.000357	0.000534	CcSEcCtD
Hydromorphone—Asthenia—Paclitaxel—ovarian cancer	0.000357	0.000534	CcSEcCtD
Hydromorphone—Pruritus—Paclitaxel—ovarian cancer	0.000352	0.000527	CcSEcCtD
Hydromorphone—Mental disorder—Epirubicin—ovarian cancer	0.000351	0.000525	CcSEcCtD
Hydromorphone—Erythema—Epirubicin—ovarian cancer	0.000348	0.000521	CcSEcCtD
Hydromorphone—Malnutrition—Epirubicin—ovarian cancer	0.000348	0.000521	CcSEcCtD
Hydromorphone—Feeling abnormal—Docetaxel—ovarian cancer	0.000347	0.00052	CcSEcCtD
Hydromorphone—Eye disorder—Doxorubicin—ovarian cancer	0.000346	0.000518	CcSEcCtD
Hydromorphone—Tinnitus—Doxorubicin—ovarian cancer	0.000345	0.000517	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000345	0.000516	CcSEcCtD
Hydromorphone—Flushing—Doxorubicin—ovarian cancer	0.000344	0.000514	CcSEcCtD
Hydromorphone—Cardiac disorder—Doxorubicin—ovarian cancer	0.000344	0.000514	CcSEcCtD
Hydromorphone—Flatulence—Epirubicin—ovarian cancer	0.000343	0.000514	CcSEcCtD
Hydromorphone—Tension—Epirubicin—ovarian cancer	0.000342	0.000512	CcSEcCtD
Hydromorphone—Dysgeusia—Epirubicin—ovarian cancer	0.000341	0.000511	CcSEcCtD
Hydromorphone—Diarrhoea—Paclitaxel—ovarian cancer	0.00034	0.000509	CcSEcCtD
Hydromorphone—Nervousness—Epirubicin—ovarian cancer	0.000338	0.000506	CcSEcCtD
Hydromorphone—Back pain—Epirubicin—ovarian cancer	0.000337	0.000504	CcSEcCtD
Hydromorphone—Angiopathy—Doxorubicin—ovarian cancer	0.000336	0.000503	CcSEcCtD
Hydromorphone—Muscle spasms—Epirubicin—ovarian cancer	0.000335	0.000501	CcSEcCtD
Hydromorphone—Immune system disorder—Doxorubicin—ovarian cancer	0.000334	0.000501	CcSEcCtD
Hydromorphone—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000334	0.000499	CcSEcCtD
Hydromorphone—Body temperature increased—Docetaxel—ovarian cancer	0.000333	0.000499	CcSEcCtD
Hydromorphone—Abdominal pain—Docetaxel—ovarian cancer	0.000333	0.000499	CcSEcCtD
Hydromorphone—Chills—Doxorubicin—ovarian cancer	0.000332	0.000497	CcSEcCtD
Hydromorphone—Arrhythmia—Doxorubicin—ovarian cancer	0.000331	0.000495	CcSEcCtD
Hydromorphone—Dizziness—Paclitaxel—ovarian cancer	0.000329	0.000492	CcSEcCtD
Hydromorphone—Vision blurred—Epirubicin—ovarian cancer	0.000328	0.000491	CcSEcCtD
Hydromorphone—Mental disorder—Doxorubicin—ovarian cancer	0.000324	0.000486	CcSEcCtD
Hydromorphone—Ill-defined disorder—Epirubicin—ovarian cancer	0.000323	0.000484	CcSEcCtD
Hydromorphone—Malnutrition—Doxorubicin—ovarian cancer	0.000322	0.000482	CcSEcCtD
Hydromorphone—Erythema—Doxorubicin—ovarian cancer	0.000322	0.000482	CcSEcCtD
Hydromorphone—Agitation—Epirubicin—ovarian cancer	0.00032	0.000479	CcSEcCtD
Hydromorphone—Flatulence—Doxorubicin—ovarian cancer	0.000318	0.000475	CcSEcCtD
Hydromorphone—Tension—Doxorubicin—ovarian cancer	0.000316	0.000473	CcSEcCtD
Hydromorphone—Vomiting—Paclitaxel—ovarian cancer	0.000316	0.000473	CcSEcCtD
Hydromorphone—Dysgeusia—Doxorubicin—ovarian cancer	0.000316	0.000472	CcSEcCtD
Hydromorphone—Malaise—Epirubicin—ovarian cancer	0.000314	0.00047	CcSEcCtD
Hydromorphone—Rash—Paclitaxel—ovarian cancer	0.000314	0.000469	CcSEcCtD
Hydromorphone—Dermatitis—Paclitaxel—ovarian cancer	0.000313	0.000469	CcSEcCtD
Hydromorphone—Nervousness—Doxorubicin—ovarian cancer	0.000313	0.000469	CcSEcCtD
Hydromorphone—Vertigo—Epirubicin—ovarian cancer	0.000313	0.000468	CcSEcCtD
Hydromorphone—Syncope—Epirubicin—ovarian cancer	0.000312	0.000468	CcSEcCtD
Hydromorphone—Leukopenia—Epirubicin—ovarian cancer	0.000312	0.000467	CcSEcCtD
Hydromorphone—Back pain—Doxorubicin—ovarian cancer	0.000312	0.000467	CcSEcCtD
Hydromorphone—Headache—Paclitaxel—ovarian cancer	0.000312	0.000466	CcSEcCtD
Hydromorphone—Hypersensitivity—Docetaxel—ovarian cancer	0.000311	0.000465	CcSEcCtD
Hydromorphone—Muscle spasms—Doxorubicin—ovarian cancer	0.00031	0.000464	CcSEcCtD
Hydromorphone—Palpitations—Epirubicin—ovarian cancer	0.000308	0.000461	CcSEcCtD
Hydromorphone—Loss of consciousness—Epirubicin—ovarian cancer	0.000306	0.000458	CcSEcCtD
Hydromorphone—Cough—Epirubicin—ovarian cancer	0.000304	0.000455	CcSEcCtD
Hydromorphone—Vision blurred—Doxorubicin—ovarian cancer	0.000304	0.000455	CcSEcCtD
Hydromorphone—Asthenia—Docetaxel—ovarian cancer	0.000302	0.000453	CcSEcCtD
Hydromorphone—Convulsion—Epirubicin—ovarian cancer	0.000302	0.000452	CcSEcCtD
Hydromorphone—Hypertension—Epirubicin—ovarian cancer	0.000301	0.00045	CcSEcCtD
Hydromorphone—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000299	0.000448	CcSEcCtD
Hydromorphone—Pruritus—Docetaxel—ovarian cancer	0.000298	0.000446	CcSEcCtD
Hydromorphone—Myalgia—Epirubicin—ovarian cancer	0.000297	0.000444	CcSEcCtD
Hydromorphone—Arthralgia—Epirubicin—ovarian cancer	0.000297	0.000444	CcSEcCtD
Hydromorphone—Chest pain—Epirubicin—ovarian cancer	0.000297	0.000444	CcSEcCtD
Hydromorphone—Agitation—Doxorubicin—ovarian cancer	0.000296	0.000443	CcSEcCtD
Hydromorphone—Anxiety—Epirubicin—ovarian cancer	0.000296	0.000442	CcSEcCtD
Hydromorphone—Nausea—Paclitaxel—ovarian cancer	0.000295	0.000442	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000295	0.000441	CcSEcCtD
Hydromorphone—Discomfort—Epirubicin—ovarian cancer	0.000293	0.000439	CcSEcCtD
Hydromorphone—Malaise—Doxorubicin—ovarian cancer	0.000291	0.000435	CcSEcCtD
Hydromorphone—Dry mouth—Epirubicin—ovarian cancer	0.00029	0.000434	CcSEcCtD
Hydromorphone—Vertigo—Doxorubicin—ovarian cancer	0.00029	0.000433	CcSEcCtD
Hydromorphone—Syncope—Doxorubicin—ovarian cancer	0.000289	0.000433	CcSEcCtD
Hydromorphone—Leukopenia—Doxorubicin—ovarian cancer	0.000289	0.000432	CcSEcCtD
Hydromorphone—Diarrhoea—Docetaxel—ovarian cancer	0.000288	0.000432	CcSEcCtD
Hydromorphone—Confusional state—Epirubicin—ovarian cancer	0.000287	0.000429	CcSEcCtD
Hydromorphone—Palpitations—Doxorubicin—ovarian cancer	0.000285	0.000426	CcSEcCtD
Hydromorphone—Anaphylactic shock—Epirubicin—ovarian cancer	0.000284	0.000426	CcSEcCtD
Hydromorphone—Loss of consciousness—Doxorubicin—ovarian cancer	0.000283	0.000424	CcSEcCtD
Hydromorphone—Infection—Epirubicin—ovarian cancer	0.000282	0.000423	CcSEcCtD
Hydromorphone—Cough—Doxorubicin—ovarian cancer	0.000281	0.000421	CcSEcCtD
Hydromorphone—Shock—Epirubicin—ovarian cancer	0.00028	0.000419	CcSEcCtD
Hydromorphone—Convulsion—Doxorubicin—ovarian cancer	0.000279	0.000418	CcSEcCtD
Hydromorphone—Nervous system disorder—Epirubicin—ovarian cancer	0.000279	0.000417	CcSEcCtD
Hydromorphone—Dizziness—Docetaxel—ovarian cancer	0.000279	0.000417	CcSEcCtD
Hydromorphone—Hypertension—Doxorubicin—ovarian cancer	0.000278	0.000417	CcSEcCtD
Hydromorphone—Tachycardia—Epirubicin—ovarian cancer	0.000277	0.000415	CcSEcCtD
Hydromorphone—Skin disorder—Epirubicin—ovarian cancer	0.000276	0.000413	CcSEcCtD
Hydromorphone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000275	0.000411	CcSEcCtD
Hydromorphone—Myalgia—Doxorubicin—ovarian cancer	0.000274	0.000411	CcSEcCtD
Hydromorphone—Arthralgia—Doxorubicin—ovarian cancer	0.000274	0.000411	CcSEcCtD
Hydromorphone—Chest pain—Doxorubicin—ovarian cancer	0.000274	0.000411	CcSEcCtD
Hydromorphone—Anxiety—Doxorubicin—ovarian cancer	0.000273	0.000409	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000273	0.000408	CcSEcCtD
Hydromorphone—Discomfort—Doxorubicin—ovarian cancer	0.000271	0.000406	CcSEcCtD
Hydromorphone—Anorexia—Epirubicin—ovarian cancer	0.000271	0.000406	CcSEcCtD
Hydromorphone—Dry mouth—Doxorubicin—ovarian cancer	0.000268	0.000402	CcSEcCtD
Hydromorphone—Vomiting—Docetaxel—ovarian cancer	0.000268	0.000401	CcSEcCtD
Hydromorphone—Rash—Docetaxel—ovarian cancer	0.000266	0.000398	CcSEcCtD
Hydromorphone—Hypotension—Epirubicin—ovarian cancer	0.000266	0.000398	CcSEcCtD
Hydromorphone—Dermatitis—Docetaxel—ovarian cancer	0.000266	0.000397	CcSEcCtD
Hydromorphone—Confusional state—Doxorubicin—ovarian cancer	0.000265	0.000397	CcSEcCtD
Hydromorphone—Headache—Docetaxel—ovarian cancer	0.000264	0.000395	CcSEcCtD
Hydromorphone—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000263	0.000394	CcSEcCtD
Hydromorphone—Infection—Doxorubicin—ovarian cancer	0.000261	0.000391	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000259	0.000388	CcSEcCtD
Hydromorphone—Shock—Doxorubicin—ovarian cancer	0.000259	0.000387	CcSEcCtD
Hydromorphone—Nervous system disorder—Doxorubicin—ovarian cancer	0.000258	0.000386	CcSEcCtD
Hydromorphone—Insomnia—Epirubicin—ovarian cancer	0.000257	0.000385	CcSEcCtD
Hydromorphone—Tachycardia—Doxorubicin—ovarian cancer	0.000257	0.000384	CcSEcCtD
Hydromorphone—Skin disorder—Doxorubicin—ovarian cancer	0.000256	0.000382	CcSEcCtD
Hydromorphone—Paraesthesia—Epirubicin—ovarian cancer	0.000255	0.000382	CcSEcCtD
Hydromorphone—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000254	0.000381	CcSEcCtD
Hydromorphone—Dyspnoea—Epirubicin—ovarian cancer	0.000253	0.000379	CcSEcCtD
Hydromorphone—Somnolence—Epirubicin—ovarian cancer	0.000253	0.000378	CcSEcCtD
Hydromorphone—Anorexia—Doxorubicin—ovarian cancer	0.000251	0.000375	CcSEcCtD
Hydromorphone—Nausea—Docetaxel—ovarian cancer	0.00025	0.000375	CcSEcCtD
Hydromorphone—Dyspepsia—Epirubicin—ovarian cancer	0.00025	0.000375	CcSEcCtD
Hydromorphone—Decreased appetite—Epirubicin—ovarian cancer	0.000247	0.00037	CcSEcCtD
Hydromorphone—Hypotension—Doxorubicin—ovarian cancer	0.000246	0.000368	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000245	0.000367	CcSEcCtD
Hydromorphone—Fatigue—Epirubicin—ovarian cancer	0.000245	0.000367	CcSEcCtD
Hydromorphone—Constipation—Epirubicin—ovarian cancer	0.000243	0.000364	CcSEcCtD
Hydromorphone—Pain—Epirubicin—ovarian cancer	0.000243	0.000364	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00024	0.000359	CcSEcCtD
Hydromorphone—Insomnia—Doxorubicin—ovarian cancer	0.000238	0.000356	CcSEcCtD
Hydromorphone—Paraesthesia—Doxorubicin—ovarian cancer	0.000236	0.000354	CcSEcCtD
Hydromorphone—Dyspnoea—Doxorubicin—ovarian cancer	0.000235	0.000351	CcSEcCtD
Hydromorphone—Feeling abnormal—Epirubicin—ovarian cancer	0.000234	0.000351	CcSEcCtD
Hydromorphone—Somnolence—Doxorubicin—ovarian cancer	0.000234	0.00035	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000232	0.000348	CcSEcCtD
Hydromorphone—Dyspepsia—Doxorubicin—ovarian cancer	0.000232	0.000347	CcSEcCtD
Hydromorphone—Decreased appetite—Doxorubicin—ovarian cancer	0.000229	0.000342	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000227	0.00034	CcSEcCtD
Hydromorphone—Fatigue—Doxorubicin—ovarian cancer	0.000227	0.000339	CcSEcCtD
Hydromorphone—Urticaria—Epirubicin—ovarian cancer	0.000226	0.000338	CcSEcCtD
Hydromorphone—Constipation—Doxorubicin—ovarian cancer	0.000225	0.000337	CcSEcCtD
Hydromorphone—Pain—Doxorubicin—ovarian cancer	0.000225	0.000337	CcSEcCtD
Hydromorphone—Body temperature increased—Epirubicin—ovarian cancer	0.000225	0.000336	CcSEcCtD
Hydromorphone—Abdominal pain—Epirubicin—ovarian cancer	0.000225	0.000336	CcSEcCtD
Hydromorphone—Feeling abnormal—Doxorubicin—ovarian cancer	0.000217	0.000324	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000215	0.000322	CcSEcCtD
Hydromorphone—Hypersensitivity—Epirubicin—ovarian cancer	0.000209	0.000314	CcSEcCtD
Hydromorphone—Urticaria—Doxorubicin—ovarian cancer	0.000209	0.000313	CcSEcCtD
Hydromorphone—Abdominal pain—Doxorubicin—ovarian cancer	0.000208	0.000311	CcSEcCtD
Hydromorphone—Body temperature increased—Doxorubicin—ovarian cancer	0.000208	0.000311	CcSEcCtD
Hydromorphone—Asthenia—Epirubicin—ovarian cancer	0.000204	0.000305	CcSEcCtD
Hydromorphone—Pruritus—Epirubicin—ovarian cancer	0.000201	0.000301	CcSEcCtD
Hydromorphone—Diarrhoea—Epirubicin—ovarian cancer	0.000195	0.000291	CcSEcCtD
Hydromorphone—Hypersensitivity—Doxorubicin—ovarian cancer	0.000194	0.00029	CcSEcCtD
Hydromorphone—Asthenia—Doxorubicin—ovarian cancer	0.000189	0.000282	CcSEcCtD
Hydromorphone—Dizziness—Epirubicin—ovarian cancer	0.000188	0.000281	CcSEcCtD
Hydromorphone—Pruritus—Doxorubicin—ovarian cancer	0.000186	0.000279	CcSEcCtD
Hydromorphone—Vomiting—Epirubicin—ovarian cancer	0.000181	0.000271	CcSEcCtD
Hydromorphone—Diarrhoea—Doxorubicin—ovarian cancer	0.00018	0.000269	CcSEcCtD
Hydromorphone—Rash—Epirubicin—ovarian cancer	0.000179	0.000268	CcSEcCtD
Hydromorphone—Dermatitis—Epirubicin—ovarian cancer	0.000179	0.000268	CcSEcCtD
Hydromorphone—Headache—Epirubicin—ovarian cancer	0.000178	0.000267	CcSEcCtD
Hydromorphone—Dizziness—Doxorubicin—ovarian cancer	0.000174	0.00026	CcSEcCtD
Hydromorphone—Nausea—Epirubicin—ovarian cancer	0.000169	0.000253	CcSEcCtD
Hydromorphone—Vomiting—Doxorubicin—ovarian cancer	0.000167	0.00025	CcSEcCtD
Hydromorphone—Rash—Doxorubicin—ovarian cancer	0.000166	0.000248	CcSEcCtD
Hydromorphone—Dermatitis—Doxorubicin—ovarian cancer	0.000166	0.000248	CcSEcCtD
Hydromorphone—Headache—Doxorubicin—ovarian cancer	0.000165	0.000247	CcSEcCtD
Hydromorphone—Nausea—Doxorubicin—ovarian cancer	0.000156	0.000234	CcSEcCtD
